纤维性肺部沙丘病 - - 从发病到管理
Ewa Łyżwa1, Jacek Wakuliński2, Monika Szturmowicz1
11st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
Journal of clinical medicine
|April 12, 2025
概括
Sarcoidosis 可以导致肺纤维化,这是一个严重的并发症. 了解其免疫学基础和多学科管理是改善患者治疗结果的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 病理学 病理学 病理学
背景情况:
- Sarcoidosis是一种多系统颗粒状疾病,原因不明.
- 肺纤维化是沙尔科毒症死亡的一个重要原因.
- 驱动纤维化的免疫机制越来越被理解.
研究的目的:
- 审查目前关于纤维化肺癌型硬化症的知识.
- 讨论影响纤维化发展和预后的因素.
- 概述当前和潜在的治疗策略.
主要方法:
- 关于沙尔科毒症和肺纤维化最近研究的文献综述.
- 对纤维化所涉及的免疫机制的分析.
- 对临床,生物标志物,成像和功能数据进行管理的评估.
主要成果:
- 纤维化病原体包括改变的淋巴细胞和巨细胞活动.
- 矩阵金属蛋白酶及其抑制剂的不平衡会导致纤维化.
- 最佳的管理需要采用多学科的方法,考虑各种临床因素.
结论:
- 纤维性肺部样症需要一个全面的管理策略.
- 需要进一步的研究,以建立关于抗纤维素剂使用的共识.
- 了解疾病机制对于改善预后和治疗至关重要.
相关概念视频
COPD: Pathogenesis and Clinical Features
193
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
193
Pulmonary Tuberculosis II
201
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
201
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Cystic Fibrosis: Management
110
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
110
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
136
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
136


